(2026). Effectiveness and Safety of Telmisartan Plus Amlodipine Compared to Telmisartan Plus Cilnidipine in Indian Patients with Hypertension and Renal Impairment: A Randomized, Open Label, Post Marketing Study (START Renal). International Journal of Nephrology and Renovascular Disease.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Effectiveness and Safety of Telmisartan Plus Amlodipine Compared to Telmisartan Plus Cilnidipine in Indian Patients with Hypertension and Renal Impairment: A Randomized, Open Label, Post Marketing Study (START Renal)."
International Journal of Nephrology and Renovascular Disease 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Effectiveness and Safety of Telmisartan Plus Amlodipine Compared to Telmisartan Plus Cilnidipine in Indian Patients with Hypertension and Renal Impairment: A Randomized, Open Label, Post Marketing Study (START Renal)."
International Journal of Nephrology and Renovascular Disease, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.